Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BetterLife Pharma Inc C.BETR

Alternate Symbol(s):  BETRF

BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical and is a non-hallucinogenic and non- controlled lysergic acid diethylamide (LSD) derivative in development and that is unregulated and therefore can be self-administered. Its synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent, for composition and method of use, covers treatment of major depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders. BETR-002, which is in preclinical and is based on honokiol, the active anxiolytic ingredient of magnolia bark. Its pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency. It also owns a drug candidate for the treatment of viral infections.


CSE:BETR - Post by User

Comment by goldmikeon Dec 21, 2020 11:27am
163 Views
Post# 32152708

RE:RE:RE:RE:RE:BetterLife Pharma (BETR) let’s go.....

RE:RE:RE:RE:RE:BetterLife Pharma (BETR) let’s go.....

BETR stock might hit $10 and here is why  just Look up Synairgen (SNG.L) gained by 456% in a single day on news of positive results from its clinical trial of SNG001, an inhaled formulation of interferon beta, in hospitalised COVID-19 patientsBETR has its own COVID-19 therapeutic called AP-003, an inhaled formulation of interferon alpha 2b (IFNa2b)BETR's AP-003 inhalation applies INFa2b directly to the lungswhich may enable infected cells to halt viral replicationAP-003 inhalation may help to restore the initial immune response to COVID-19. Reports over the weekend of a new more contagious strain of COVID-19will create renewed interest in COVID-19 therapeutics.
$400M competitor.. looking to hold betterlife is coming big 

<< Previous
Bullboard Posts
Next >>